Xanthones

1,8-Dihydroxy-3-methylxanthone is a naturally occurring xanthone derivative, which is often sourced from plants known for their therapeutic properties. This compound is distinguished by its aromatic and polyphenolic structure, typically extracted from the roots or bark of certain plant species. Its mode of action is largely attributed to its ability to interact with biological membranes and proteins, often resulting in antioxidant, anti-inflammatory, and potential anticancer activities. In scientific research, 1,8-Dihydroxy-3-methylxanthone is employed for investigating the mechanisms of cellular protection and the modulation of enzyme activities. It is often utilized in experimental studies focusing on the development of new therapeutic agents due to its potent biological activities. Researchers explore its effects on cell lines and its potential for incorporation into pharmaceutical formulations aimed at treating various diseases. This compound's comprehensive role in pharmacological research underscores its significance in the discovery and development of novel medical therapies.

3,6-Dihydroxyxanthone is a naturally occurring compound classified as a xanthone, which is a type of polyphenolic compound. It is primarily sourced from various plant species, notably those within the Gentianaceae family. This compound exhibits a range of biological activities due to its ability to interact with multiple molecular targets within biological systems. The mode of action of 3,6-Dihydroxyxanthone involves its function as an antioxidant, as well as its potential to inhibit specific enzymes and modulate signaling pathways, contributing to its diverse biological effects. In scientific research, 3,6-Dihydroxyxanthone is utilized for its potential therapeutic applications, particularly in studying its anti-inflammatory, anticancer, and antimicrobial properties. Its ability to scavenge free radicals and mitigate oxidative stress makes it a compound of interest in the development of treatments for various oxidative stress-related diseases. Furthermore, its enzyme inhibitory characteristics are being explored in relation to metabolic and degenerative disorders. Ongoing studies aim to further elucidate the compound's mechanisms and expand its applicability in pharmaceutical and nutraceutical formulations.

Iriflophenone 3-C-β-D-glucopyranoside is a glucoside compound, which is a naturally occurring chemical constituent often found in certain plant species. It is typically isolated from members of the genus *Garcinia*, a group of flowering plants known for their diverse secondary metabolites. The mode of action of Iriflophenone 3-C-β-D-glucopyranoside involves its role as an antioxidant, potentially offering protection against oxidative stress by scavenging free radicals. This compound may also exhibit other bioactivities such as anti-inflammatory or anti-microbial effects, although these require further elucidation through research. Iriflophenone 3-C-β-D-glucopyranoside’s applications primarily lie in the fields of pharmacology and biochemistry, where it is studied for its potential health benefits and therapeutic uses. Researchers focus on its efficacy in preventing or mitigating oxidative damage, which is implicated in various chronic conditions and diseases. Understanding the precise mechanisms and effects of Iriflophenone 3-C-β-D-glucopyranoside could lead to its development into a useful agent in medicinal chemistry or as a dietary supplement ingredient.

3,8-Dihydroxy-6-methylxanthone is a bioactive compound, classified as a xanthone derivative, which is primarily sourced from various plants, including those in the Gentianaceae and Clusiaceae families. Xanthones are polyphenolic compounds known for their diverse pharmacological activities. This particular derivative exhibits a range of biological activities owing to its unique chemical structure. It acts by interacting with multiple biological pathways, including antioxidative, anti-inflammatory, and antimicrobial mechanisms. The hydroxyl groups on its structure contribute to its potent free radical scavenging ability, thus mitigating oxidative stress in biological systems. The compound is under investigation for its potential uses in pharmaceutical and nutraceutical applications. Researchers are particularly interested in its efficacy in developing treatments for chronic conditions such as cancer, cardiovascular diseases, and neurodegenerative disorders. The ongoing studies and interest in 3,8-Dihydroxy-6-methylxanthone highlight its potential as a lead compound in drug discovery and development, aiming to harness its natural properties for therapeutic benefits.

2-Hydroxy-5,6,7,8-tetramethoxyxanthone is a naturally occurring xanthone derivative, which is often isolated from various plant species known for their medicinal properties. As a xanthone compound, it is characterized by a tricyclic aromatic scaffold embellished with methoxy and hydroxy groups. This molecular structure contributes to its potent antioxidant properties, allowing it to scavenge free radicals effectively. This compound demonstrates a range of biological activities, primarily through its ability to modulate oxidative stress pathways and inhibit certain enzymatic activities. These actions make it a subject of interest in the development of therapeutic agents targeting conditions associated with oxidative damage. The potential applications of 2-Hydroxy-5,6,7,8-tetramethoxyxanthone are broad, with research exploring its efficacy in areas such as anti-inflammatory treatments, neuroprotection, and cancer therapy. Its ability to mitigate oxidative stress makes it a promising candidate for further pharmacological study, with ongoing research aiming to fully decipher its mechanisms and enhance its therapeutic potential.

Mangiferin (MF) and its glucosides (mangiferin-7-O-beta-glucoside) (MG) isolated from Anemarrhena asphodeloides Bunge rhizome, have antidiabetic activity in KK-Ay mice,

1,5,6-Trihydroxyxanthone is a natural xanthone derivative, which is commonly isolated from various plant sources, particularly in the family Gentianaceae. This compound is characterized by its polyhydroxylated xanthone structure, contributing to its diverse biological functionalities. Xanthones, including 1,5,6-Trihydroxyxanthone, are known for their ability to modulate oxidative pathways and interact with cellular signaling mechanisms. The mode of action of 1,5,6-Trihydroxyxanthone involves its antioxidant activity, where it scavenges free radicals, thereby protecting cellular components from oxidative damage. Furthermore, this compound may exhibit inhibition of enzymes involved in inflammatory pathways, suggesting potential anti-inflammatory effects. 1,5,6-Trihydroxyxanthone finds applications in various scientific fields, including pharmacological research, where it is investigated for its potential therapeutic effects. Studies focus on its roles in modulating oxidative stress, inflammation, and potentially contributing to cancer research due to its ability to influence cellular signaling pathways. This compound serves as a valuable subject for investigating natural products with potential health benefits.

1,3-Dimethoxy-5,8-dihydroxyxanthone is a naturally occurring xanthone compound, which is a type of polyphenolic compound. It is derived from certain plant species, often found in the families Guttiferae and Gentianaceae. The compound exhibits various bioactive properties attributed to its molecular structure, allowing it to interact with biological targets within cellular systems. The mode of action of 1,3-Dimethoxy-5,8-dihydroxyxanthone involves its ability to modulate oxidative stress responses and inflammatory processes through the inhibition of specific enzymes and pathways, such as cyclooxygenase and lipoxygenase, that are crucial in various cellular signaling mechanisms. Additionally, it may influence apoptotic pathways, providing potential cytotoxic effects against cancerous cells. Applications of 1,3-Dimethoxy-5,8-dihydroxyxanthone include its use in research focused on its anti-inflammatory, antioxidant, and anticancer properties. It can be employed in the development of novel therapeutics and in the study of mechanisms underlying its biological activity. The compound's potential in pharmacological research offers promising avenues for the exploration of new drug candidates targeting oxidative stress-mediated conditions.

Neomangiferin is a bioactive compound, which is a xanthone glucoside derived from the leaves, bark, or roots of Mangifera indica, commonly known as the mango tree. Its molecular structure enables it to engage in multiple biochemical interactions, primarily through antioxidant, anti-inflammatory, and immunomodulatory mechanisms. The compound's antioxidant properties result from its ability to scavenge free radicals and reduce oxidative stress, while its anti-inflammatory action is associated with the inhibition of key inflammatory mediators. Neomangiferin's therapeutic applications are diverse. It has been extensively studied for its potential role in managing metabolic disorders, including diabetes, due to its ability to modulate glucose metabolism. Additionally, its neuroprotective effects suggest possible applications in preventing neurodegenerative diseases. The compound's ability to modulate immune responses opens avenues for its use in treating autoimmune conditions. Ongoing research continues to explore its potential benefits across a range of therapeutic areas, highlighting its significance as a natural, plant-derived compound with promising pharmacological properties.

3,8-Dimethoxyxanthone is an organic compound, which is a type of xanthone derivative. It is primarily sourced from natural plant extracts, particularly those found in certain tropical and subtropical regions. This compound is synthesized via the oxidative coupling of phenolic precursors and subsequent methylation, a process leveraged due to its presence in various plant species. 3,8-Dimethoxyxanthone exhibits multiple modes of action, including potential antioxidant, anti-inflammatory, and cytotoxic activities. At the cellular level, it may interact with enzymatic pathways, modulating oxidative stress responses and attenuating inflammatory mediators, thereby highlighting its pharmacological versatility. In scientific research, 3,8-Dimethoxyxanthone is primarily investigated for its potential therapeutic applications in treating conditions like cancer and inflammatory diseases. Researchers are particularly interested in its ability to induce apoptosis in cancer cells and its role in minimizing inflammation through molecular pathway modulation. As a subject of pharmacological studies, this compound continues to garner interest for its potential efficacy and safety in preclinical and clinical settings.

Isomangiferin is a C-glucosyl xanthone, which is a naturally occurring polyphenolic compound derived primarily from the leaves of the mango tree, Mangifera indica. This compound is one of the many bioactive components found in mangoes, renowned for its contribution to the plant's defense system against environmental stress. The mode of action of isomangiferin involves its potent antioxidant properties, which enable it to scavenge free radicals effectively, thereby mitigating oxidative stress. Furthermore, it exhibits anti-inflammatory activities by modulating key signaling pathways and inhibiting the production of pro-inflammatory cytokines. These biochemical actions make isomangiferin a compound of considerable interest in combating oxidative-linked cellular damage and inflammation-related disorders. The applications of isomangiferin are broad, spanning both the pharmaceutical and nutraceutical fields. It is studied extensively for its potential in therapeutic formulations aimed at treating chronic conditions such as neurodegenerative diseases, diabetes, and cardiovascular disorders. Additionally, its incorporation into functional foods and dietary supplements is being explored to enhance both the nutritional and therapeutic profiles of these products.

1-Hydroxyxanthone is a synthetic xanthone derivative, which is a type of organic compound known for its diverse bioactive properties. Derived from natural sources such as plants in the Guttiferae family, xanthones are renowned for their therapeutic potential. 1-Hydroxyxanthone specifically is obtained through chemical synthesis, allowing for greater purity and batch-to-batch consistency, which is beneficial for scientific research. The mode of action of 1-Hydroxyxanthone involves its interaction with biological pathways that may lead to antioxidant, antimicrobial, or anticancer activities. This compound has been observed to modulate various cellular processes, including apoptosis and enzyme inhibition, which could contribute to its biological effects. 1-Hydroxyxanthone finds applications primarily in biochemical and pharmacological research. It serves as a valuable tool in exploring new therapeutic agents due to its potential effects on human health. Researchers utilize this compound to investigate its efficacy and mechanism of action in vitro and in vivo, contributing to the broader understanding of xanthones and their derivatives in medicinal chemistry. Its unique properties make it a focal point for studies aiming to discover novel treatments and elucidate the biological mechanisms of action.

1-Hydroxy-3,4,5-trimethoxyxanthone is a naturally occurring xanthone compound, which is derived from various plant sources, particularly in the Gentianaceae and Hypericaceae families. The plant-based origin allows it to be isolated through extraction and purification processes from medicinal herbs known for their bioactive properties. The primary mode of action for 1-hydroxy-3,4,5-trimethoxyxanthone involves modulating various biochemical pathways, including antioxidant, anti-inflammatory, and anticancer mechanisms. It functions by scavenging free radicals, inhibiting pro-inflammatory mediators, and interacting with cellular targets involved in cell proliferation and apoptosis. This compound has notable uses and applications in scientific research, particularly in the fields of pharmacology and medicinal chemistry. Researchers investigate its potential as a therapeutic agent for treating conditions such as cancer, cardiovascular diseases, and other inflammation-related disorders. The exploratory studies aim to elucidate its efficacy and safety profiles, providing insights into its potential role in the development of new drugs and therapeutic strategies.

Gentisein trimethylether is a specific flavonoid derivative, which is synthesized from naturally occurring isoflavones. It belongs to a class of polyphenolic compounds widely studied for their pharmacological properties. Derived from plant sources, Gentisein trimethylether emerges through specific biosynthetic pathways involving methylation processes, which enhance its stability and bioavailability. The mode of action of Gentisein trimethylether primarily involves interactions at the molecular level, including binding to various cellular targets such as enzymes and receptors. This interaction can modulate signaling pathways and potentially influence gene expression, showcasing its role in numerous biochemical processes. Gentisein trimethylether is of significant interest due to its potential applications in scientific research, particularly in the fields of oncology, endocrinology, and anti-inflammatory studies. Given its structural attributes, it serves as a useful tool for probing into the mechanisms of action of related flavonoids and for developing novel therapeutic agents based on its framework. Its diverse biological activity profiles underscore the importance of this compound in advancing our understanding of complex biological systems and in the pursuit of innovative therapeutic solutions.

Sibiricaxanthone B is a natural product from Polygala tenuifolia.

Neomangiferin exhibits antidiabetic and antiosteoporotic actions; it has beneficial effects on high fat diet-induced nonalcoholic fatty liver disease in rats, it also modulates the Th17/Treg balance and ameliorates colitis in mice.

Flemiphilippin A has antioxidant activity, it shows DPPH radical scavenging activity with effective half maximal concentration (EC50) of 18.36 ug/mL. Flemiphilippinin A (5 ug/mL) exhibits some level of antitumor activity against human hepatocellular carcinoma cell (BEL-7402), human lung epithelial (A-549) and human ileocecal adenocarcinoma cell (HCT-8).

Please enquire for more information about Gentisein including the price, delivery time and more detailed product information at the technical inquiry form on this page

Gentisein-3,7-dimethylether is a naturally occurring flavonoid, which is derived from specific plant sources. This compound is a methoxylated derivative of genistein, a well-known isoflavone found in various plants, particularly in soy. The mode of action of Gentisein-3,7-dimethylether involves its function as an antioxidant, where it scavenges free radicals and inhibits oxidative stress pathways. This biochemical activity makes it a molecule of interest in the prevention of oxidative damage at the cellular level. The applications of Gentisein-3,7-dimethylether extend into research focusing on its potential therapeutic benefits, particularly in the fields of oncology, cardioprotection, and neuroprotection. Studies suggest that this compound may exhibit anti-inflammatory and anti-cancer properties, making it a valuable subject for further investigation in disease models. In addition, its ability to modulate signaling pathways and enzyme activities relevant to cell proliferation and apoptosis further highlights its scientific importance. However, while promising, the translation of these properties into clinical applications necessitates thorough investigation and validation through empirical studies.

Cowaxanthone B is a naturally occurring xanthone compound, which is isolated from the fruiting bodies of Garcinia species, a genus known for its diverse range of biologically active phytochemicals. This compound is characterized by its tetracyclic chemical structure, which contributes to its unique biological properties. The mode of action of Cowaxanthone B involves modulation of various cellular pathways, including apoptosis induction, and inhibition of cell proliferation, which is mediated through interaction with specific molecular targets within the cell. Research into Cowaxanthone B is ongoing, with particular interest in its potential therapeutic applications as an anticancer agent. Its ability to selectively target cancer cells while exhibiting minimal toxicity to normal cells presents a promising avenue for the development of new chemotherapeutic drugs. Additionally, Cowaxanthone B has been studied for its antioxidant and anti-inflammatory effects, which may further contribute to its potential utility in the treatment and prevention of various diseases beyond cancer. Further exploration is required to elucidate its full spectrum of biological activities and mechanisms, as well as to optimize its bioavailability and efficacy in clinical settings.

Tovophyllin A is a methylxanthine compound, which is an alkaloid derived from natural plant sources. It is primarily found in abundance within the seeds, leaves, and fruit of various plants, including coffee beans, tea leaves, and cocoa seeds. The mode of action of Tovophyllin A involves the inhibition of phosphodiesterase enzymes, which leads to an increase in cyclic adenosine monophosphate (cAMP) levels. This biochemical action results in smooth muscle relaxation, notably within the bronchial airways, thereby exhibiting bronchodilator effects. The uses and applications of Tovophyllin A are primarily focused on the treatment of respiratory disorders such as asthma and chronic obstructive pulmonary disease (COPD). Due to its ability to relax and dilate the bronchial muscles, it serves to alleviate breathing difficulties associated with these conditions. Additionally, Tovophyllin A may have a role in stimulating the central nervous system and providing mild diuretic effects, although its primary function remains in respiratory therapy. Its scientific significance is noteworthy, as it offers a natural origin alternative to synthetic bronchodilators in clinical applications.

Notch and gamma-secretase inhibitor

Homomangiferin is a xanthone derivative, which is extracted primarily from the leaves of the mango tree, Mangifera indica. This natural compound belongs to a class of polyphenolic compounds known for their potential health benefits and is most notably sourced from various parts of the mango plant, including its leaves and bark. The mechanism of action of homomangiferin involves its potent antioxidant activity. It scavenges free radicals and reduces oxidative stress, thereby potentially mitigating cellular damage. This activity is attributed to its ability to interact with reactive oxygen species and enhance the body's endogenous antioxidant defenses. In addition to its antioxidant capabilities, homomangiferin exhibits anti-inflammatory properties through the modulation of inflammatory mediators. The uses and applications of homomangiferin are of significant interest in biomedical research. It has been studied for its potential role in the prevention and treatment of various oxidative stress-related diseases, including cardiovascular diseases and certain types of cancer. Moreover, its anti-inflammatory properties make it a candidate for research into therapies for inflammatory conditions. Despite promising results in preclinical studies, further research is required to fully elucidate its therapeutic potential and translate it into clinical applications.

Garcinone D is a xanthone derivative, which is a naturally occurring compound extracted from the fruit rind of the Garcinia species, notably Garcinia mangostana. This compound is characterized by its bioactive profile, which has been studied for various pharmacological effects. The source of Garcinone D, Garcinia mangostana, is a tropical fruit commonly known as mangosteen. This fruit has been used traditionally in various cultures for its health benefits, attributed to its rich content of xanthones, a class of polyphenolic compounds. The mode of action of Garcinone D involves multiple biochemical pathways, including its ability to inhibit cancer cell proliferation through the induction of apoptosis and cell cycle arrest. Additionally, it exhibits anti-inflammatory and antioxidant activities, which contribute to its potential protective effects against oxidative stress-related diseases. In terms of uses and applications, Garcinone D is primarily of interest in the field of oncology, where it is being researched for its potential as an anti-cancer agent. Its ability to impede the growth of various cancer cell lines makes it a compound of significant interest for developing new therapeutic strategies. Additionally, its anti-inflammatory properties suggest potential applications in treating chronic inflammatory diseases.